Statement of Retraction: Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer
2024

Retraction of Study on Lung Cancer Treatment

publication

Author Information

Author(s): Xuan Zhou, Ting Jin, Likun Wang, Erlin Zhao, Xuyang Xiao

Conclusion

The article was retracted due to significant concerns about the integrity of the data and reported results.

Supporting Evidence

  • The authors did not provide their original data or any necessary supporting information.
  • The integrity of the scholarly record is essential, leading to the retraction.

Takeaway

The study on a lung cancer treatment was taken back because the authors couldn't prove their results were correct.

Digital Object Identifier (DOI)

10.1080/21655979.2024.2299626

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication